Viracta Therapeutics Company
Viracta Therapeutics is a precision oncology company focused on new treatment of virus-associated malignancies.
Industry:
Biopharma, Biotechnology, Medical, Pharmaceutical, Therapeutics
Last Funding Type:
Post-IPO Equity
Funding Status:
IPO
Estimated Revenue:
$10M to $50M
Total Funding:
184899999
Investors Number:
19
Headquarters:
Cardiff By The Sea, California, United States
Technology:
Cancer
Investor Type:
IPO
Last Funding Date:
2021
Founded Date:
2007
Employee Number:
11-50